(3-Oxo-2,3-dihydro-1H-inden-5-yl)boronic acid, 95%, 250mg

2-(2,5-Dibromophenoxy)ethanol, 95+%, 1g

4-(5-Nitropyridin-2-yl)morpholine, 95.0%, 100g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 97%, 5g

(5R,6S,7R)-5-(hydroxymethyl)-2-(methylamino)-3a,6,7,7a-tetrahydro-5H-pyrano[3,2-d]thiazole-6,7-diol, 97%, 100mg

Aminocyclobutane>97.0%(GC)(T)1mL

(3R)-1-Methylpyrrolidin-3-amine hydrochloride, 95%, 100mg

ETHYL 3-METHYL-4,5,6,7-TETRAHYDRO-2H-INDAZOLE-5-CARBOXYLATE, 95.0%, 5g

3-(Trifluoroacetyl)indole, 99.0%, 1g

2-Bromo-5-ethoxy-4-hydroxy-benzonitrile, 97.0%, 1g

2-(2-chlorophenoxy)-N-(4-iodo-2-methylphenyl)acetamide, 95.0%, 1g

2,5-Difluoropyridine, 98.00%, 100g

2-(tert-Butoxycarbonyl)-2-azaspiro[3.4]octane-1-carboxylic acid, 98%, 100mg